15.1 Pharmacology I: Cardiovascular, Pain, Anti-inflammatory, and Steroid Medications

15.1 Pharmacology I: Cardiovascular, Pain, Anti-inflammatory, and Steroid Medications

Quick Answer: Modern acupuncture practice requires fluency in biomedical pharmacology to prevent adverse events, recognize drug-induced clinical mimics, and modify needling safely. Cardiovascular drugs present specific challenges: ACE inhibitors (lisinopril) cause a dry, non-productive hacking cough (bradykinin accumulation) and angioedema; Beta-blockers (metoprolol) cause bradycardia and blunt adrenergic hypoglycemic warning signs (tachycardia, tremor) in diabetics; Calcium Channel Blockers (amlodipine) cause dependent bilateral ankle edema and gingival hyperplasia; Diuretics (furosemide, hydrochlorothiazide) cause hypokalemia, dehydration, and hyperuricemic gout flares. Anticoagulants (Warfarin, target INR 2.0–3.0; DOACs like apixaban/Eliquis and rivaroxaban/Xarelto) and Antiplatelets (aspirin, clopidogrel) cause severe hematoma risks, requiring fine-gauge needles, gentle insertion, prolonged direct pressure, and absolute contraindication of wet cupping and vigorous gua sha. Statins (atorvastatin) induce myopathy and rhabdomyolysis presenting as bilateral proximal muscle pain and tea-colored urine with elevated creatine kinase. Endocrine, psychiatric, anti-infective, and other drug classes on the outline are covered in Section 15.2.

---

The Clinical Intersection of Pharmacology and East Asian Medicine

In modern integrative clinical practice, an acupuncturist frequently evaluates patients receiving multi-drug regimens for complex chronic diseases. Pharmaceutical agents alter baseline physiology, modify autonomic tone, suppress immune responses, and alter vascular integrity. Board examinations regularly evaluate an examinee's ability to identify adverse drug effects, distinguish drug toxicities from primary East Asian pattern disharmonies, and apply appropriate safety protocols.

+----------------------------------------------------------------------------+
|            PHARMACOLOGICAL SAFETY SCREENING ARCHITECTURE                   |
+----------------------------------------------------------------------------+
|  [Cardiovascular Agents]   --> Hypotension, bradycardia, bleeding, edema   |
|  [Anticoagulants / DOACs]  --> Severe hematoma, microtrauma, INR checks    |
|  [Lipid-Lowering Statins]  --> Statin myopathy vs. myofascial pain mimic   |
|  [Analgesics / NSAIDs]     --> GI bleeding, masked inflammation, renal fail|
|  [Corticosteroids]         --> Osteoporosis, skin fragility, HPA collapse   |
|  [Endocrine / Diabetic]    --> Hypoglycemia, lactic acidosis, euglycemic DKA|
|  [Psychiatric / SSRIs]     --> Serotonin syndrome, sedation, withdrawal    |
|  [Fluoroquinolones]        --> Black box warning for Achilles tendon rupture|
+----------------------------------------------------------------------------+

---

Cardiovascular Medications

Cardiovascular drugs represent the most commonly prescribed pharmaceutical class in outpatient adult populations. These agents directly alter blood pressure, cardiac output, vascular tone, fluid volume, and coagulation pathways.

In-Depth Antihypertensive Clinical Dynamics

1. ACE Inhibitor Cough vs. Lung Disharmony: Up to 20% of patients receiving lisinopril or enalapril develop a persistent, dry, non-productive, hacking nocturnal cough. The mechanism is pharmacological: ACE is identical to kininase II, the pulmonary enzyme responsible for degrading bradykinin and substance P. When ACE is blocked, bradykinin accumulates in the bronchial mucosa, stimulating sensory C-fibers and provoking bronchoconstriction and dry cough. In an acupuncture clinic, this presentation is frequently misattributed to Lung Yin Deficiency or Wind-Dryness attacking the Lung. Acupuncturists must cross-reference medication lists; the cough is completely refractory to antitussive herbs and resolves only when the patient's physician substitutes an ARB (e.g., losartan).
2. Beta-Blocker Blunting of Hypoglycemia: In healthy individuals, an acute drop in blood glucose triggers a robust sympathoadrenal discharge of epinephrine and norepinephrine. This catecholamine surge generates classic neurogenic warning symptoms: palpitations, sinus tachycardia, anxiety, and fine muscle tremors. In a diabetic patient taking a beta-blocker (such as metoprolol or atenolol), beta-1 and beta-2 blockade extinguishes these cardiac and motor warning signs. The patient may slide precipitously into neuroglycopenia, cognitive confusion, seizures, or coma without noticing tachycardia. Crucially, diaphoresis (profuse sweating) is mediated by sympathetic cholinergic postganglionic muscarinic pathways and is not blunted by beta-blockers. Diaphoresis is therefore the primary remaining somatic indicator of acute hypoglycemia in these patients.
3. Calcium Channel Blocker Edema: Dihydropyridines (such as amlodipine) relax precapillary arteriolar smooth muscle without dilating postcapillary venules. This selective precapillary vasodilation increases intracapillary hydrostatic pressure, causing transudation of fluid into the interstitial space of dependent tissues. Patients develop bilateral ankle and lower leg edema that worsens toward the end of the day. This edema is purely hydrostatic and does not reflect cardiac ventricular failure, hepatic cirrhosis, nephrotic syndrome, or Spleen/Kidney Yang deficiency.

+----------------------------------------------------------------------------+
|                   BETA-BLOCKER HYPOGLYCEMIA BLUNTING                       |
+----------------------------------------------------------------------------+
|  Sympathetic Adrenergic Signs (BLUNTED by beta-blockers):                  |
|  - Tachycardia / Palpitations     --> [BLOCKED]                            |
|  - Fine hand tremors              --> [BLOCKED]                            |
|  - Subjective anxiety / agitation --> [BLOCKED]                            |
|                                                                            |
|  Sympathetic Cholinergic Signs (PRESERVED / NOT blunted):                  |
|  - Profuse diaphoresis (sweating) --> [INTACT CLINICAL WARNING SIGN]       |
+----------------------------------------------------------------------------+

Anticoagulants and Antiplatelet Therapies

Anticoagulants and antiplatelet drugs inhibit the coagulation cascade or suppress platelet aggregation. These medications are ubiquitous in patients with atrial fibrillation, mechanical prosthetic heart valves, deep vein thrombosis (DVT), pulmonary embolism (PE), ischemic stroke, and coronary stenting.

Lipid-Lowering Statins: The Musculoskeletal Mimic

Statins (HMG-CoA reductase inhibitors: atorvastatin, simvastatin, rosuvastatin, pravastatin) are prescribed to lower low-density lipoprotein cholesterol (LDL-C) and reduce cardiovascular events. Statins inhibit the conversion of HMG-CoA to mevalonate, depleting downstream metabolites including ubiquinone (coenzyme Q10 / CoQ10), which impairs mitochondrial respiration in skeletal myocytes.

• Spectrum of Statin Muscle Toxicity:
  • Statin-Associated Muscle Symptoms (SAMS) / Myalgia: Muscle aching, soreness, stiffness, or cramping without significant enzyme elevation; occurs in 5% to 15% of treated patients.
  • Myositis / Myopathy: Muscle symptoms accompanied by objective muscle weakness and elevation of serum Creatine Kinase (CK) to greater than 10 times the upper limit of normal (>10x ULN).
  • Rhabdomyolysis: Severe, life-threatening skeletal muscle breakdown resulting in the leakage of massive quantities of intracellular contents—myoglobin, potassium, and CK—into the systemic circulation.
• The Clinical Trap for Acupuncturists: Patients frequently present to an acupuncture clinic with a chief complaint of "new-onset generalized fibromyalgia," "worsening lumbar strain," or "bilateral shoulder and hip stiffness" within weeks to months of starting a statin or increasing its dosage. Misinterpreting this presentation as simple Qi and Blood stagnation or Bi syndrome delays critical biomedical intervention.
• Diagnostic Red Flags for Rhabdomyolysis:
  1. Bilateral, symmetrical proximal muscle weakness and deep muscular tenderness (affecting the quadriceps, gluteal muscles, and shoulder girdle).
  2. Dark, reddish-brown "tea-colored" or "cola-colored" urine, indicating profound myoglobinuria.
  3. Serum Creatine Kinase (CK) levels elevated from several thousand to >50,000 U/L.
  4. Hyperkalemia, hyperphosphatemia, and acute kidney injury (tubular obstruction by filtered myoglobin casts).
  5. Immediate Action: Withhold all manual therapy; instruct the patient to immediately discontinue the statin under medical direction; arrange urgent emergency department transport for aggressive intravenous fluid hydration to preserve renal function.

---

Anti-Angina Medications

If a patient with known angina has chest pain in the clinic, have them rest and take their prescribed nitroglycerin. If the pain is not improved or is worsening 5 minutes after the first dose, call 911. Chest pain in a patient without a known diagnosis needs 911 immediately.

Analgesics, Anti-inflammatories, and Corticosteroids

Patients seeking acupuncture for chronic pain frequently consume over-the-counter and prescription analgesics. These agents carry profound gastrointestinal, hepatic, renal, and skeletal toxicities.

+----------------------------------------------------------------------------+
|             ANALGESIC & ANTI-INFLAMMATORY ADVERSE PROFILE                  |
+----------------------------------------------------------------------------+
|  NSAIDs:          GI ulceration/perforation, renal vasoconstriction        |
|  Acetaminophen:   NAPQI metabolite hepatotoxicity (safe max: 3-4 g/day)    |
|  Corticosteroids: Osteoporosis, HPA axis collapse, skin thinning, diabetes |
|  Opioids:         Fatal respiratory depression, miosis, unremitting constip|
+----------------------------------------------------------------------------+

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

• Mechanisms: Non-selective NSAIDs (ibuprofen, naproxen, ketorolac, meloxicam) inhibit both Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2). Selective NSAIDs (celecoxib) selectively inhibit COX-2.
• Gastrointestinal Toxicity: COX-1 produces mucosal prostaglandins (PGI2, PGE2) that stimulate gastric mucus and bicarbonate secretion while maintaining mucosal blood flow. Non-selective NSAIDs strip these protective mechanisms, causing erosive gastritis, gastric and duodenal ulcers, and life-threatening gastrointestinal hemorrhage. NSAID ulcers are notoriously "silent," presenting with painless melena (black tarry stools), hematemesis (coffee-ground emesis), or acute hemorrhagic shock.
• Renal Toxicity: In states of reduced effective circulating volume, renal blood flow depends critically on vasodilatory prostaglandins (PGE2, PGI2) acting on the afferent renal arteriole. NSAIDs extinguish prostaglandin synthesis, causing afferent arteriolar constriction, decreased glomerular filtration rate (GFR), acute tubular necrosis, hyperkalemia, and secondary fluid retention that exacerbates hypertension and congestive heart failure.
• Cardiovascular Hazards: All NSAIDs (except aspirin, and to a lesser extent naproxen) carry an FDA black box warning for increased risks of myocardial infarction and ischemic stroke, driven by unbalanced suppression of vasodilatory endothelial prostacyclin relative to platelet thromboxane A2.

Acetaminophen (Tylenol / APAP)

• Mechanism: Acts predominantly within the central nervous system to inhibit prostaglandin synthesis and modulate cannabinoid/serotonergic pathways; possesses analgesic and antipyretic efficacy but lacks significant peripheral anti-inflammatory or antiplatelet activity.
• Metabolism and Hepatotoxicity: At therapeutic doses, 90% of acetaminophen is safely conjugated in the liver via glucuronidation and sulfation. Approximately 5% to 10% is metabolized by cytochrome P450 (specifically CYP2E1) into a highly reactive, toxic electrophilic intermediate: N-acetyl-p-benzoquinone imine (NAPQI). Under normal conditions, NAPQI is rapidly detoxified by covalent binding to hepatic glutathione and excreted renally.
• Toxic Thresholds and Overdose: In acute overdose or chronic supra-therapeutic ingestion (>3,000 to 4,000 mg/day in healthy adults, or >2,000 mg/day in chronic alcoholics, elderly, or malnourished patients), hepatic glutathione reserves are exhausted (>70% depletion). Unconjugated NAPQI binds covalently to cysteinyl sulfhydryl groups on hepatocyte cellular proteins, causing massive centrilobular hepatic necrosis and acute liver failure.
• Antidote: Intravenous or oral N-acetylcysteine (NAC), which replenishes intracellular glutathione stores and directly conjugates NAPQI; must be administered rapidly (ideally within 8 hours of ingestion).

Systemic Corticosteroids

Systemic glucocorticoids (prednisone, methylprednisolone, dexamethasone, hydrocortisone) are powerful anti-inflammatory and immunosuppressive agents. Prolonged systemic administration (>2–3 weeks) generates profound multisystem adverse effects:

• Osteoporosis and Pathological Fractures: Glucocorticoids suppress osteoblast proliferation, stimulate osteoclast longevity, inhibit intestinal calcium absorption, and stimulate renal calcium excretion. Trabecular bone is lost rapidly, creating extreme vulnerability to pathological vertebral compression fractures, rib fractures, and femoral neck fractures. Acupuncturists must strictly avoid aggressive spinal joint manipulation, heavy cupping pressure, or forceful manual pressure along the spine.
• Adrenal Suppression and Addisonian Crisis: Exogenous glucocorticoids exert negative feedback on the hypothalamus (CRH) and anterior pituitary (ACTH), causing bilateral atrophy of the adrenal cortex. If the patient abruptly discontinues the corticosteroid without a structured taper, the atrophied adrenal glands cannot produce endogenous cortisol. The patient slides into an acute adrenal (Addisonian) crisis: severe refractory hypotension, vascular collapse, severe hypoglycemia, vomiting, and shock.
• Integumentary and Connective Tissue Fragility: Corticosteroids inhibit fibroblastic collagen synthesis, producing extreme skin thinning ("cigarette-paper skin"), cutaneous atrophy, capillary fragility, extensive senile purpura, and severely delayed wound healing. Needling must be performed with fine-gauge needles, and retention tapes or press seeds must be removed with extreme gentleness to avoid tearing fragile epidermis.
• Steroid-Induced Hyperglycemia: Stimulates hepatic gluconeogenesis and impairs peripheral glucose uptake, destabilizing diabetic control and precipitating new-onset diabetes mellitus.
• Aseptic Osteonecrosis (Avascular Necrosis): Corticosteroid use is the leading non-traumatic cause of avascular necrosis of the femoral head. Any patient on long-term prednisone who develops deep groin or anterior hip pain on weight-bearing must be evaluated immediately with pelvic MRI.
• Immunosuppression and Masked Sepsis: Corticosteroids impair leukocyte migration, lymphopenia, and suppress cytokine pyrogens. Patients with severe systemic infections (e.g., septic arthritis, spinal epidural abscess) may fail to develop a robust fever or elevated white blood cell count.

Opioid Analgesics

Opioids (morphine, oxycodone, hydrocodone, fentanyl, hydromorphone, methadone, tramadol) bind to central and peripheral mu-opioid receptors to inhibit ascending nociceptive pathways:

• The Lethal Overdose Triad: (1) Coma / Unresponsiveness, (2) Pinpoint Pupils (Miosis), and (3) Severe Respiratory Depression (respiratory rate < 8–10 breaths/min, cyanosis). Immediate administration of Naloxone (Narcan) is life-saving.
• Unremitting Opioid-Induced Constipation (OIC): Patients rapidly develop pharmacological tolerance to opioid-induced sedation, nausea, and euphoria. However, patients never develop tolerance to constipation or miosis. Mu receptors in the myenteric plexus continuously inhibit gastrointestinal peristalsis and mucosal secretion, producing refractory constipation that requires bowel regimens (stimulant laxatives, peripherally acting mu-opioid receptor antagonists like methylnaltrexone).

---